Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
PlanB: Bitcoin Shows Significant Divergence from Stock Market and Gold Correlation; Whether a 10x Rally Will Repeat Remains to Be Seen

PlanB: Bitcoin Shows Significant Divergence from Stock Market and Gold Correlation; Whether a 10x Rally Will Repeat Remains to Be Seen

BlockBeatsBlockBeats2025/12/27 13:40
Show original

BlockBeats News, December 27, PlanB posted that the current price of bitcoin is about $87,500, which has clearly deviated from its historical correlation range with the US stock market and gold. Based on past correlations, the corresponding bitcoin price ranges for the US stock market and gold are approximately $6,900 and $4,500, respectively, indicating that BTC is in a significant "decoupling" state.


PlanB pointed out that a similar correlation divergence occurred when bitcoin was below $1,000, which eventually triggered an approximately 10-fold rally. However, he also reminded that if the correlation relationship has been structurally broken, this cycle's trend may differ from history, and the final outcome still needs time to be verified.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.

The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.

智通财经2026/09/21 07:31

Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD

Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.

智通财经2026/09/21 07:16

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11